MATTHEW M. LOAR

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

Oncotelic Therapeutics, Inc.

Filing Date Source Excerpt
2016-10-03 Includes 46,875 shares Mr. Loar has the right to acquire currently or within 60 days of September 15, 2016, upon the exercise of options.

Data sourced from SEC filings. Last updated: 2025-10-11